SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 386.47-0.2%Dec 5 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TobagoJack who wrote (1726)10/28/2005 10:27:43 AM
From: elmatador  Read Replies (1) of 218196
 
They learned with Brazil!!! "charging excessive and disproportionate royalties," Brazil tell the pharmaceuticals that charges too much money for the medicine to drop the prices else we make genericals.

Brazil gets discount on AIDS drugs
Beginning in March of next year the price will come down from US$1.17 per capsule to US$0.63, reports the minister of Health, Saraiva Felipe, who explains that the discount will mean an economy of around US$340 million over a five-year period (2006 to 2011).

Meanwhile the Abbott lab announced it will donate some US$3 million in other antiretroviral drugs and diagnostic kits. It also said it is studying a discount for Brazil on a new drug, Meltrex, which is still in tests in the US.

internacional.radiobras.gov.br
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext